Literature DB >> 24705774

The accuracy of magnetic resonance imaging in prostate cancer staging: a single-institution experience.

S F Oon1, S P Power, J S Kelly, V McDermott, P Ryan, P C Ryan.   

Abstract

BACKGROUND: Magnetic resonance imaging (MRI) has a wide reported variation in sensitivity and specificity for staging prostate cancer (PCA). AIMS: We examined the accuracy of MRI in detecting PCA, and in identifying extracapsular extension (ECE) and seminal vesicle invasion (SVI) in PCA patients at our institution.
METHODS: We retrospectively reviewed pre-biopsy MRI findings and correlated the same with subsequent radical prostatectomy pathology reports in all patients undergoing radical prostatectomy between 2010 and 2012. Specifically, comparison was made between MRI and pathologic stage. Age, serum prostate-specific antigen level and Gleason score were recorded.
RESULTS: MRI detected signal abnormalities in 50 out of 88 PCA patients undergoing radical prostatectomy. Of these, 12 had ECE and 7 had SVI on final histology. The sensitivity and specificity of MRI for detecting ECE were 75 and 100%, respectively. The sensitivity and specificity of MRI for detecting SVI were 16.7 and 100%, respectively. The positive predictive values for determining ECE and SVI were 100% and negative predictive values were 96.2 and 90.6%, respectively.
CONCLUSIONS: MRI may be reliable for excluding ECE and SVI in PCA patients where the lesion is visible on MRI. It has a good diagnostic ability for ECE, but is less accurate for identifying SVI. This article supports the use of MRI in the preoperative evaluation of PCA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24705774     DOI: 10.1007/s11845-014-1109-0

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  23 in total

1.  Endorectal magnetic resonance imaging has limited clinical ability to preoperatively predict pT3 prostate cancer.

Authors:  Jonathan S Brajtbord; Hugh J Lavery; Fatima Nabizada-Pace; Prathibha Senaratne; David B Samadi
Journal:  BJU Int       Date:  2010-08-26       Impact factor: 5.588

2.  A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.

Authors:  Koichiro Akakura; Hiroyoshi Suzuki; Tomohiko Ichikawa; Hiroyuki Fujimoto; Osamu Maeda; Michiyuki Usami; Daisaku Hirano; Yukie Takimoto; Toshiyuki Kamoto; Osamu Ogawa; Yoshiteru Sumiyoshi; Jun Shimazaki; Tadao Kakizoe
Journal:  Jpn J Clin Oncol       Date:  2006-11-02       Impact factor: 3.019

3.  Conventional imaging and multiparametric magnetic resonance (MRI, MRS, DWI, MRP) in the diagnosis of prostate cancer.

Authors:  V Panebianco; A Sciarra; A Marcantonio; V Forte; T Biondi; A Laghi; C Catalano
Journal:  Q J Nucl Med Mol Imaging       Date:  2012-08       Impact factor: 2.346

4.  [Dynamic contrast-enhanced MRI of the prostate: comparison of two different post-processing algorithms].

Authors:  D Beyersdorff; L Lüdemann; E Dietz; D Galler; P Marchot; T Franiel
Journal:  Rofo       Date:  2011-03-25

5.  Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis.

Authors:  K K Yu; H Hricak; R Alagappan; D M Chernoff; P Bacchetti; C J Zaloudek
Journal:  Radiology       Date:  1997-03       Impact factor: 11.105

6.  EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.

Authors:  Axel Heidenreich; Joaquim Bellmunt; Michel Bolla; Steven Joniau; Malcolm Mason; Vsevolod Matveev; Nicolas Mottet; Hans-Peter Schmid; Theo van der Kwast; Thomas Wiegel; Filliberto Zattoni
Journal:  Eur Urol       Date:  2010-10-28       Impact factor: 20.096

7.  Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.

Authors:  John F Ward; Jeffrey M Slezak; Michael L Blute; Erik J Bergstralh; Horst Zincke
Journal:  BJU Int       Date:  2005-04       Impact factor: 5.588

Review 8.  Epstein criteria for insignificant prostate cancer.

Authors:  Sheng F Oon; R William Watson; John J O'Leary; John M Fitzpatrick
Journal:  BJU Int       Date:  2011-02-14       Impact factor: 5.588

9.  Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective, multi-institutional trial.

Authors:  J A Smith; P T Scardino; M I Resnick; A D Hernandez; S C Rose; M J Egger
Journal:  J Urol       Date:  1997-03       Impact factor: 7.450

Review 10.  Magnetic resonance image in the diagnosis and evaluation of extra-prostatic extension and involvement of seminal vesicles of prostate cancer: a systematic review of literature and meta-analysis.

Authors:  Rogerio Cardoso da Silva; Andre Deeke Sasse; Wagner Eduardo Matheus; Ubirajara Ferreira
Journal:  Int Braz J Urol       Date:  2013 Mar-Apr       Impact factor: 1.541

View more
  2 in total

1.  The association between seminal vesicle size and duration of abstinence from ejaculation.

Authors:  E Yuruk; A W Pastuszak; J M Suggs; A Colakerol; E C Serefoglu
Journal:  Andrologia       Date:  2016-09-23       Impact factor: 2.775

2.  Prostate MRI prior to radical prostatectomy: effects on nerve sparing and pathological margin status.

Authors:  Sasha C Druskin; Jen-Jane Liu; Allen Young; Zhaoyong Feng; Seyed S Dianat; Wesley W Ludwig; Bruce J Trock; Katarzyna J Macura; Christian P Pavlovich
Journal:  Res Rep Urol       Date:  2017-04-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.